New multiple sclerosis drug Ocrevus is approved in Korea - dailypharmkorea

Ho Jin Kim, Professor of Neurology, the National Cancer Center A new drug for multiple sclerosis (MS), an intractable disease characterized by a high relapse rate, has been introduced to...

Multiple Sclerosis | National Institute of Neurological Disorders and Stroke

On this page ; What is multiple sclerosis? ; Who is more likely to get multiple sclerosis? ; How is multiple sclerosis diagnosed and treated?

FDA approves new oral drug to treat multiple sclerosis | FDA

The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-...

FDA approves new oral treatment for multiple sclerosis | FDA

FDA approves Mayzent (cladribine), a new oral drug to treat multiple sclerosis

FDA approves new drug to treat multiple sclerosis | FDA

On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis...

New drug gives hope for those with progressive multiple sclerosis - CBS News

As many as 400,000 Americans are believed to suffer from multiple sclerosis, and a new drug may provide relief from the most devastating form of MS

FDA Approves First Biosimilar to Treat Multiple Sclerosis | FDA

Food and Drug Administration today approved Tyruko... of multiple sclerosis (MS). Tyruko, like Tysabri, is also... of new neurological symptoms followed by periods of stability; and Active...

Medications for Multiple Sclerosis

WebMD looks at disease-modifying drugs, their uses and side effects , and explains how they slow the progression of multiple sclerosis.

Treatments for Multiple Sclerosis Planning to Talk to Your Doctor About Your RRMS Treatment Options?

Learn about your options for treating multiple sclerosis (MS), including different types of disease-modifying drugs, various therapies, and lifestyle changes.

Therapeutic decision making in a new drug era in multiple sclerosis

******.*****@****.*** Abstract Multiple sclerosis is a presumed autoimmune, inflammatory... offer new therapeutic alternatives to MS patients and their treating providers. It remains...